codevelopment agreement Thermo Fisher, Oncocyte Ink Development, Comarketing Deal for Cancer IVDs The companies are working together to bring to market in vitro diagnostic versions of Thermo Fisher's Oncomine Comprehensive Assay Plus and Oncocyte's DetermaIO test. Illumina, SomaLogic Ink Codevelopment Agreement for Proteomics Assays With Sequencing Readout Illumina will endeavor to integrate SomaLogic's aptamer-based protein counting technology with its NGS and bioinformatics platforms by 2024. Sophia Genetics Touts Informatics Deals With Weill Cornell, Agilent, Dasa Premium Fresh off its July IPO, the Swiss-American company is expanding its technological and geographical footprints with a series of collaborations and partnerships. Thermo Fisher Scientific, AstraZeneca Team up to Develop CDx for Targeted Drugs The next-generation sequencing based companion diagnostics will be paired with targeted therapies that are being developed for several diseases. GenomSys, Philips to Build Genome Analysis Technology Based on MPEG-G Standard The multiyear collaboration agreement brings together two of the corporate champions of the MPEG-G genomic data representation and compression standard. Jul 6, 2021 Sophia Genetics Files for $100M IPO, Inks Cancer Data Deal With GE Healthcare Apr 22, 2021 Illumina, Kartos Therapeutics Partner to Develop TP53 Companion Diagnostic Apr 15, 2021 Trapelo Health, Magellan Hope to Ease Prior Authorization for Precision Oncology Testing Premium Feb 24, 2021 Qiagen, Inovio Expand CDx Partnership, Starting With NGS Test for Cervical Dysplasia Therapy Feb 9, 2021 UK Startup Gabriel Precision Oncology Leans on Congenica to Broaden NGS Use in Cancer Testing Premium Nov 18, 2020 Agendia, Paige Partner to Codevelop New Assays Using MammaPrint, BluePrint Signatures Aug 6, 2020 Biocept, Aegea to Develop PCR-based COVID-19 Assay Using Switch-Blocker Tech Jul 17, 2020 Saga Diagnostics, SensID to Codevelop Control Reagents for Cancer Mutation Detection Jul 1, 2020 Sherlock Biosciences, Binx Health Partner to Develop CRISPR-Based POC COVID-19 Test Premium May 5, 2020 CareDx, Weill Cornell Codeveloping Kidney Transplant Rejection Test Mar 17, 2020 Illumina, IDbyDNA Ink Partnership on NGS Technologies for Infectious Disease Jan 15, 2020 PGDx, Eisai to Develop Next-Generation Sequencing Biomarker Assay Jan 13, 2020 Roche, Illumina Partner on Next-Generation Sequencing IVD, CDx Development, Marketing Dec 3, 2019 Illumina, ArcherDx Expand Partnership on NGS IVD Tests Nov 7, 2019 Lucence Diagnostics, MEDx Partner on Companion Diagnostic Cancer Tests in China Nov 6, 2019 Mission Bio, BioLegend Partner on Single-Cell DNA-Protein Detection Oct 4, 2019 Prometheus Biosciences, Takeda Pharmaceutical to Codevelop Targeted Therapies, CDx for IBD Sep 24, 2019 Foundation Medicine, Natera to Develop Liquid Biopsy Monitoring Assays Sep 16, 2019 Interpace Diagnostics, Genecast Biotechnology Ink Worldwide Research Services Agreement Sep 11, 2019 Roche-GE Partnership Integrating Molecular Data Into Navify Tumor Board Premium Load More Breaking News Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.